INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

74,396 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
14
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$154K
2,600 sh
Sep 14, 2026
Page 430 of 1860
← PrevNext →
Sep 15, 2026
traded Sep 14, 2026
+1d
SEC Form 4

Evidence

14
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Option exercise
M—
123.1K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

14
HM
Hancock MarkDirector, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$922K
21.1K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

14
HM
Hancock MarkDirector, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$298K
6,634 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

14
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Option exercise
M—
125.0K sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

14
MF
Montoya Michael FChief Technology Ops Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$33K
80 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

14
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$582K
9,615 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

14
AN
Agrawal NitinChief Financial Officer
CRWVCoreWeave, Inc.
Option exercise
M—
122.3K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

13
RJ
Rozenblat JennaPresident
REAXReal REMAX Group Inc.
Disposition to issuer
D—
608 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

13
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
4,483 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
2,101 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

13
WW
Weibel Paul Wesley IIIChief Executive Officer
FEAM5E Advanced Materials, Inc.
Tax withholding
F$2,317
1,839 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
120 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

13
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$44K
9,273 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Tax withholding
F$3,806
1,069 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

13
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$12K
775 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
80 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

13
CJ
Cooke JulieChief Human Resources Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
3,587 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

13
HP
Hill Jesse P.Chief Financial Officer
AGNTAGNT, Inc.
Option exercise
M—
1,161 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
120 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
223 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

13
LA
Lumpkin AlexandraChief Legal Officer
REAXReal REMAX Group Inc.
Option exercise
M—
304 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$19K
80 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

13
DP
Damani PriteshChief Technology Officer
REAXReal REMAX Group Inc.
Option exercise
M—
1,285 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

13
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
752 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

13
MA
Maddison John AnthonyChief Product Mkting Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$83K
204 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
80 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
80 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$8,800
40 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
80 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

13
CE
Cooper Jeffrey ElliottChief Financial Officer
GWREGuidewire Software, Inc.
Option exercise
M—
37.8K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

13
RJ
Rozenblat JennaPresident
REAXReal REMAX Group Inc.
Option exercise
M—
914 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

13
DP
Damani PriteshChief Technology Officer
REAXReal REMAX Group Inc.
Disposition to issuer
D—
834 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$45K
200 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

12
MR
Mehl RandallDirector
KFRCKFORCE INC
Other acquisition or disposition
J—
235 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

12
CC
Cloudman CatherineDirector
KFRCKFORCE INC
Other acquisition or disposition
J—
64 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

12
BD
Brooks Derrick DewanDirector
KFRCKFORCE INC
Other acquisition or disposition
J—
38 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

12
TG
Thomas Andrew GChief Experience Officer
KFRCKFORCE INC
Other acquisition or disposition
J—
338 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

12
BD
Brooks Derrick DewanDirector
KFRCKFORCE INC
Other acquisition or disposition
J—
83 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

11
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$334K
13.2K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence